Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiong-Cheng Wu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ACS Biomaterials Science & Engineering|August 22, 2024
Stimuli-Responsive Nanomaterials for Tumor ImmunotherapyXiang-Peng Li, Da-Yong Hou, Jiong-Cheng Wu, et al.
Nature Communications|June 12, 2026
Integrated theranostic nanoplatform empowers precision cancer care via radionuclide-labeled NIR-II aggregation-induced emission luminogensGuo-Ling Zhang, Da-Yong Hou, Yixuan Chen, et al.
Biomaterials|July 17, 2025
Translational contrast agents for use in fluorescence image-guided tumor surgeryDa-Yong Hou, Xiang-Peng Li, Yue-Ze Wang, et al.
ACS Nano|December 17, 2024
Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder CancerDa-Yong Hou, Qing You, Peng Zhang, et al.
Science Bulletin|November 13, 2024
In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasisDa-Yong Hou, Ni-Yuan Zhang, Peng Zhang, et al.
Biomaterials|June 29, 2026
In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilizationPeng Zhang, Jiong-Cheng Wu, Haoran Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Biomaterials Science & Engineering|August 22, 2024
Stimuli-Responsive Nanomaterials for Tumor ImmunotherapyXiang-Peng Li, Da-Yong Hou, Jiong-Cheng Wu, et al.
Nature Communications|June 12, 2026
Integrated theranostic nanoplatform empowers precision cancer care via radionuclide-labeled NIR-II aggregation-induced emission luminogensGuo-Ling Zhang, Da-Yong Hou, Yixuan Chen, et al.
Biomaterials|July 17, 2025
Translational contrast agents for use in fluorescence image-guided tumor surgeryDa-Yong Hou, Xiang-Peng Li, Yue-Ze Wang, et al.
ACS Nano|December 17, 2024
Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder CancerDa-Yong Hou, Qing You, Peng Zhang, et al.
Science Bulletin|November 13, 2024
In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasisDa-Yong Hou, Ni-Yuan Zhang, Peng Zhang, et al.
Biomaterials|June 29, 2026
In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilizationPeng Zhang, Jiong-Cheng Wu, Haoran Wang, et al.
Pageof 1